ATLANTA – Elekta (EKTA-B.ST) today announced that its oncology information system, Elekta ONE OIS powered by MOSAIQ®*, has earned the “Best in KLAS” designation in the 2025 Best in KLAS: Software and Services Report. Elekta ONE OIS ranked number one in the Oncology (Radiation) category. Based on feedback from thousands of U.S.-based providers who use oncology software, the awards are based on evaluations collected by KLAS, an independent research firm.

A fixture in many of the world’s leading cancer care facilities, Elekta ONE OIS provides comprehensive image, data and workflow management with advanced automation, streamlined user interfaces and intuitive, task-driven workstreams to improve and advance radiation therapy processes. It also is the multidisciplinary backbone of the company’s Elekta ONE** software suite. Elekta ONE brings all Elekta software products, solutions and services under one umbrella and includes radiation therapy planning, comprehensive treatment management and delivery.

"With Elekta ONE OIS, we’re pushing the innovation envelope by building an open, connected oncology healthcare ecosystem with intelligent and accessible tools that not only enhance patient outcomes, but staff well-being,” says Anish Patankar, SVP and Head of Elekta’s Oncology Software Solutions Business Line. “Achieving the Best in KLAS designation is a testament to Elekta’s unwavering commitment to our customers and the trust they place in us. Our secure technology, scalable SaaS packages, and robust cloud infrastructure are all part of the company’s ongoing mission to make it easy for our users to boost productivity."

“At Elekta, we are committed to being a trusted partner and aim to deliver exceptional service and support across our entire portfolio, including Elekta ONE,” says Ardie Ermers, Executive Vice President, Region Americas. "Being named Best in KLAS shows the confidence our customers have in the Elekta team and our software. Our ability to generate innovative product and service solutions – whether through cloud-based connectivity, remote support, or education – ensures that our customers stay connected to their colleagues, data, and patients throughout the entire care journey."

The 2025 report showed that Elekta ONE OIS outperformed competitors in several categories. User feedback was measured across several areas, including culture, loyalty, operations, product, relationships, and value.

Elekta will receive the award on March 3 during the “Best in KLAS Awards Show” at HIMSS25 in Las Vegas.

*Elekta ONE OIS powered by MOSAIQ is not available in all markets.
**Elekta ONE is comprised of multiple Elekta solutions, some of which may not yet be available in all markets.

# # #

For further information, please contact:
Mattias Thorsson, Vice President, Head of Corporate Communications
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com  
Time zone: CET: Central European Time

Raven Canzeri, Global Director, Media Relations
Tel: +1 770-670-2524, e-mail: Raven.Canzeri@elekta.com
Time zone: ET: Eastern Time

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com.